GSK, touting its post-spinoff future, talks up innovation and vaccine business zbecker Wed, 07/27/2022 – 11:35 More: GSK, touting its post-spinoff future, talks up innovation and vaccine business Source: fierce
read moreNot so fast on Revlimid’s fade as Bristol Myers reports sales surprise amid generic competition kdunleavy Wed, 07/27/2022 – 10:50 More: Not so fast on Revlimid's fade as Bristol Myers reports sales surprise amid generic competition Source: fierce
read moreTeva, with a $4.25B opioid settlement in hand, eyes return to growth by 2027 fkansteiner Wed, 07/27/2022 – 10:12 More: Teva, with a .25B opioid settlement in hand, eyes return to growth by 2027 Source: fierce
read moreWith ominous FDA talks, ObsEva scraps lead women’s health drug, plots layoffs in major restructuring aliu Wed, 07/27/2022 – 09:52 More: With ominous FDA talks, ObsEva scraps lead women's health drug, plots layoffs in major restructuring Source: fierce
read morePredicting which women are likely to develop pre-eclampsia will help clinicians to decide on the most appropriate care More: Roche testing to help diagnose pre-eclampsia receives NICE recommendation Source: News
read moreFirst carbon minimal pMDI is on track with the joint goal of benefitting patients and the planet More: Chiesi reinforces commitment to reducing emissions Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals